0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Veterinary Needle-free Injection Device Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: October 2025
|
Report Code: QYRE-Auto-31D17919
Home | Market Reports | Pets & Animals| Animal Products & Services| Veterinarians
Global Veterinary Needle free Injection Device Market Research Report 2024
BUY CHAPTERS

Global Veterinary Needle-free Injection Device Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-31D17919
Report
October 2025
Pages:141
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Veterinary Needle-free Injection Device Market

The global Veterinary Needle-free Injection Device market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Veterinary Needle-free Injection Device is a device used for injecting vaccines and other types of drugs into livestock. Needle-free injection technology works by forcing liquid (or powder) medication at high speed through a tiny orifice that is held against the skin. The diameter of the orifice is smaller than the diameter of a human hair. This creates an ultra- fine stream of high-pressure fluid that penetrates the skin without using a needle.
From a downstream perspective, Pigs accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Veterinary Needle-free Injection Device leading manufacturers including HIPRA, Merck, Pulse NeedleFree Systems, Inc., Henke Sass Wolf, AcuShot, NuGen Medical, Shine-moon Suzhou Animal Care, DERMU, etc., dominate supply; the top five capture approximately % of global revenue, with HIPRA leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Veterinary Needle-free Injection Device market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Veterinary Needle-free Injection Device Market Report

Report Metric Details
Report Name Veterinary Needle-free Injection Device Market
Segment by Type
  • Battery Powered
  • Compressed Gas Powered
Segment by Application
  • Pigs
  • Cattle
  • Poultry
  • Companion Animals
  • Others
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company HIPRA, Merck, Pulse NeedleFree Systems, Inc., Henke Sass Wolf, AcuShot, NuGen Medical, Shine-moon Suzhou Animal Care, DERMU
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Veterinary Needle-free Injection Device study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Veterinary Needle-free Injection Device Market report?

Ans: The main players in the Veterinary Needle-free Injection Device Market are HIPRA, Merck, Pulse NeedleFree Systems, Inc., Henke Sass Wolf, AcuShot, NuGen Medical, Shine-moon Suzhou Animal Care, DERMU

What are the Application segmentation covered in the Veterinary Needle-free Injection Device Market report?

Ans: The Applications covered in the Veterinary Needle-free Injection Device Market report are Pigs, Cattle, Poultry, Companion Animals, Others

What are the Type segmentation covered in the Veterinary Needle-free Injection Device Market report?

Ans: The Types covered in the Veterinary Needle-free Injection Device Market report are Battery Powered, Compressed Gas Powered

1 Study Coverage
1.1 Introduction to Veterinary Needle-free Injection Device: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Veterinary Needle-free Injection Device Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Battery Powered
1.2.3 Compressed Gas Powered
1.3 Market Segmentation by Application
1.3.1 Global Veterinary Needle-free Injection Device Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Pigs
1.3.3 Cattle
1.3.4 Poultry
1.3.5 Companion Animals
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Veterinary Needle-free Injection Device Revenue Estimates and Forecasts 2020-2031
2.2 Global Veterinary Needle-free Injection Device Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Veterinary Needle-free Injection Device Sales Estimates and Forecasts 2020-2031
2.4 Global Veterinary Needle-free Injection Device Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Veterinary Needle-free Injection Device Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Veterinary Needle-free Injection Device Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Battery Powered Market Size by Manufacturers
3.5.2 Compressed Gas Powered Market Size by Manufacturers
3.6 Global Veterinary Needle-free Injection Device Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Veterinary Needle-free Injection Device Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Veterinary Needle-free Injection Device Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Veterinary Needle-free Injection Device Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Veterinary Needle-free Injection Device Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Veterinary Needle-free Injection Device Sales and Revenue by Type (2020-2031)
6.4 North America Veterinary Needle-free Injection Device Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Veterinary Needle-free Injection Device Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Veterinary Needle-free Injection Device Sales and Revenue by Type (2020-2031)
7.4 Europe Veterinary Needle-free Injection Device Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Veterinary Needle-free Injection Device Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Veterinary Needle-free Injection Device Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Veterinary Needle-free Injection Device Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Veterinary Needle-free Injection Device Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Veterinary Needle-free Injection Device Sales and Revenue by Type (2020-2031)
9.4 Central and South America Veterinary Needle-free Injection Device Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Veterinary Needle-free Injection Device Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Veterinary Needle-free Injection Device Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Veterinary Needle-free Injection Device Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Veterinary Needle-free Injection Device Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 HIPRA
11.1.1 HIPRA Corporation Information
11.1.2 HIPRA Business Overview
11.1.3 HIPRA Veterinary Needle-free Injection Device Product Models, Descriptions and Specifications
11.1.4 HIPRA Veterinary Needle-free Injection Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 HIPRA Veterinary Needle-free Injection Device Sales by Product in 2024
11.1.6 HIPRA Veterinary Needle-free Injection Device Sales by Application in 2024
11.1.7 HIPRA Veterinary Needle-free Injection Device Sales by Geographic Area in 2024
11.1.8 HIPRA Veterinary Needle-free Injection Device SWOT Analysis
11.1.9 HIPRA Recent Developments
11.2 Merck
11.2.1 Merck Corporation Information
11.2.2 Merck Business Overview
11.2.3 Merck Veterinary Needle-free Injection Device Product Models, Descriptions and Specifications
11.2.4 Merck Veterinary Needle-free Injection Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Merck Veterinary Needle-free Injection Device Sales by Product in 2024
11.2.6 Merck Veterinary Needle-free Injection Device Sales by Application in 2024
11.2.7 Merck Veterinary Needle-free Injection Device Sales by Geographic Area in 2024
11.2.8 Merck Veterinary Needle-free Injection Device SWOT Analysis
11.2.9 Merck Recent Developments
11.3 Pulse NeedleFree Systems, Inc.
11.3.1 Pulse NeedleFree Systems, Inc. Corporation Information
11.3.2 Pulse NeedleFree Systems, Inc. Business Overview
11.3.3 Pulse NeedleFree Systems, Inc. Veterinary Needle-free Injection Device Product Models, Descriptions and Specifications
11.3.4 Pulse NeedleFree Systems, Inc. Veterinary Needle-free Injection Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Pulse NeedleFree Systems, Inc. Veterinary Needle-free Injection Device Sales by Product in 2024
11.3.6 Pulse NeedleFree Systems, Inc. Veterinary Needle-free Injection Device Sales by Application in 2024
11.3.7 Pulse NeedleFree Systems, Inc. Veterinary Needle-free Injection Device Sales by Geographic Area in 2024
11.3.8 Pulse NeedleFree Systems, Inc. Veterinary Needle-free Injection Device SWOT Analysis
11.3.9 Pulse NeedleFree Systems, Inc. Recent Developments
11.4 Henke Sass Wolf
11.4.1 Henke Sass Wolf Corporation Information
11.4.2 Henke Sass Wolf Business Overview
11.4.3 Henke Sass Wolf Veterinary Needle-free Injection Device Product Models, Descriptions and Specifications
11.4.4 Henke Sass Wolf Veterinary Needle-free Injection Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Henke Sass Wolf Veterinary Needle-free Injection Device Sales by Product in 2024
11.4.6 Henke Sass Wolf Veterinary Needle-free Injection Device Sales by Application in 2024
11.4.7 Henke Sass Wolf Veterinary Needle-free Injection Device Sales by Geographic Area in 2024
11.4.8 Henke Sass Wolf Veterinary Needle-free Injection Device SWOT Analysis
11.4.9 Henke Sass Wolf Recent Developments
11.5 AcuShot
11.5.1 AcuShot Corporation Information
11.5.2 AcuShot Business Overview
11.5.3 AcuShot Veterinary Needle-free Injection Device Product Models, Descriptions and Specifications
11.5.4 AcuShot Veterinary Needle-free Injection Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 AcuShot Veterinary Needle-free Injection Device Sales by Product in 2024
11.5.6 AcuShot Veterinary Needle-free Injection Device Sales by Application in 2024
11.5.7 AcuShot Veterinary Needle-free Injection Device Sales by Geographic Area in 2024
11.5.8 AcuShot Veterinary Needle-free Injection Device SWOT Analysis
11.5.9 AcuShot Recent Developments
11.6 NuGen Medical
11.6.1 NuGen Medical Corporation Information
11.6.2 NuGen Medical Business Overview
11.6.3 NuGen Medical Veterinary Needle-free Injection Device Product Models, Descriptions and Specifications
11.6.4 NuGen Medical Veterinary Needle-free Injection Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 NuGen Medical Recent Developments
11.7 Shine-moon Suzhou Animal Care
11.7.1 Shine-moon Suzhou Animal Care Corporation Information
11.7.2 Shine-moon Suzhou Animal Care Business Overview
11.7.3 Shine-moon Suzhou Animal Care Veterinary Needle-free Injection Device Product Models, Descriptions and Specifications
11.7.4 Shine-moon Suzhou Animal Care Veterinary Needle-free Injection Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Shine-moon Suzhou Animal Care Recent Developments
11.8 DERMU
11.8.1 DERMU Corporation Information
11.8.2 DERMU Business Overview
11.8.3 DERMU Veterinary Needle-free Injection Device Product Models, Descriptions and Specifications
11.8.4 DERMU Veterinary Needle-free Injection Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 DERMU Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Veterinary Needle-free Injection Device Industry Chain
12.2 Veterinary Needle-free Injection Device Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Veterinary Needle-free Injection Device Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Veterinary Needle-free Injection Device Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Veterinary Needle-free Injection Device Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Veterinary Needle-free Injection Device Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
 Table 1. Global Veterinary Needle-free Injection Device Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Veterinary Needle-free Injection Device Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Veterinary Needle-free Injection Device Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Veterinary Needle-free Injection Device Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Veterinary Needle-free Injection Device Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Veterinary Needle-free Injection Device Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
 Table 7. Global Veterinary Needle-free Injection Device Sales by Region (2020-2025) & (K Units)
 Table 8. Global Veterinary Needle-free Injection Device Sales by Region (2026-2031) & (K Units)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Veterinary Needle-free Injection Device Sales by Manufacturers (2020-2025) & (K Units)
 Table 11. Global Veterinary Needle-free Injection Device Sales Share by Manufacturers (2020-2025)
 Table 12. Global Veterinary Needle-free Injection Device Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global Veterinary Needle-free Injection Device Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global Veterinary Needle-free Injection Device by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Needle-free Injection Device as of 2024)
 Table 16. Global Veterinary Needle-free Injection Device Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global Veterinary Needle-free Injection Device Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
 Table 18. Key Manufacturers Veterinary Needle-free Injection Device Manufacturing Base and Headquarters
 Table 19. Global Veterinary Needle-free Injection Device Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Veterinary Needle-free Injection Device Sales by Type (2020-2025) & (K Units)
 Table 23. Global Veterinary Needle-free Injection Device Sales by Type (2026-2031) & (K Units)
 Table 24. Global Veterinary Needle-free Injection Device Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global Veterinary Needle-free Injection Device Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global Veterinary Needle-free Injection Device ASP by Type (2020-2031) & (US$/Unit)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global Veterinary Needle-free Injection Device Sales by Application (2020-2025) & (K Units)
 Table 29. Global Veterinary Needle-free Injection Device Sales by Application (2026-2031) & (K Units)
 Table 30. Veterinary Needle-free Injection Device High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global Veterinary Needle-free Injection Device Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global Veterinary Needle-free Injection Device Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global Veterinary Needle-free Injection Device ASP by Application (2020-2031) & (US$/Unit)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America Veterinary Needle-free Injection Device Growth Accelerators and Market Barriers
 Table 37. North America Veterinary Needle-free Injection Device Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America Veterinary Needle-free Injection Device Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe Veterinary Needle-free Injection Device Growth Accelerators and Market Barriers
 Table 40. Europe Veterinary Needle-free Injection Device Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe Veterinary Needle-free Injection Device Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific Veterinary Needle-free Injection Device Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific Veterinary Needle-free Injection Device Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific Veterinary Needle-free Injection Device Growth Accelerators and Market Barriers
 Table 45. Southeast Asia Veterinary Needle-free Injection Device Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America Veterinary Needle-free Injection Device Investment Opportunities and Key Challenges
 Table 47. Central and South America Veterinary Needle-free Injection Device Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa Veterinary Needle-free Injection Device Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa Veterinary Needle-free Injection Device Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. HIPRA Corporation Information
 Table 51. HIPRA Description and Major Businesses
 Table 52. HIPRA Product Models, Descriptions and Specifications
 Table 53. HIPRA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 54. HIPRA Sales Value Proportion by Product in 2024
 Table 55. HIPRA Sales Value Proportion by Application in 2024
 Table 56. HIPRA Sales Value Proportion by Geographic Area in 2024
 Table 57. HIPRA Veterinary Needle-free Injection Device SWOT Analysis
 Table 58. HIPRA Recent Developments
 Table 59. Merck Corporation Information
 Table 60. Merck Description and Major Businesses
 Table 61. Merck Product Models, Descriptions and Specifications
 Table 62. Merck Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 63. Merck Sales Value Proportion by Product in 2024
 Table 64. Merck Sales Value Proportion by Application in 2024
 Table 65. Merck Sales Value Proportion by Geographic Area in 2024
 Table 66. Merck Veterinary Needle-free Injection Device SWOT Analysis
 Table 67. Merck Recent Developments
 Table 68. Pulse NeedleFree Systems, Inc. Corporation Information
 Table 69. Pulse NeedleFree Systems, Inc. Description and Major Businesses
 Table 70. Pulse NeedleFree Systems, Inc. Product Models, Descriptions and Specifications
 Table 71. Pulse NeedleFree Systems, Inc. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 72. Pulse NeedleFree Systems, Inc. Sales Value Proportion by Product in 2024
 Table 73. Pulse NeedleFree Systems, Inc. Sales Value Proportion by Application in 2024
 Table 74. Pulse NeedleFree Systems, Inc. Sales Value Proportion by Geographic Area in 2024
 Table 75. Pulse NeedleFree Systems, Inc. Veterinary Needle-free Injection Device SWOT Analysis
 Table 76. Pulse NeedleFree Systems, Inc. Recent Developments
 Table 77. Henke Sass Wolf Corporation Information
 Table 78. Henke Sass Wolf Description and Major Businesses
 Table 79. Henke Sass Wolf Product Models, Descriptions and Specifications
 Table 80. Henke Sass Wolf Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 81. Henke Sass Wolf Sales Value Proportion by Product in 2024
 Table 82. Henke Sass Wolf Sales Value Proportion by Application in 2024
 Table 83. Henke Sass Wolf Sales Value Proportion by Geographic Area in 2024
 Table 84. Henke Sass Wolf Veterinary Needle-free Injection Device SWOT Analysis
 Table 85. Henke Sass Wolf Recent Developments
 Table 86. AcuShot Corporation Information
 Table 87. AcuShot Description and Major Businesses
 Table 88. AcuShot Product Models, Descriptions and Specifications
 Table 89. AcuShot Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 90. AcuShot Sales Value Proportion by Product in 2024
 Table 91. AcuShot Sales Value Proportion by Application in 2024
 Table 92. AcuShot Sales Value Proportion by Geographic Area in 2024
 Table 93. AcuShot Veterinary Needle-free Injection Device SWOT Analysis
 Table 94. AcuShot Recent Developments
 Table 95. NuGen Medical Corporation Information
 Table 96. NuGen Medical Description and Major Businesses
 Table 97. NuGen Medical Product Models, Descriptions and Specifications
 Table 98. NuGen Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 99. NuGen Medical Recent Developments
 Table 100. Shine-moon Suzhou Animal Care Corporation Information
 Table 101. Shine-moon Suzhou Animal Care Description and Major Businesses
 Table 102. Shine-moon Suzhou Animal Care Product Models, Descriptions and Specifications
 Table 103. Shine-moon Suzhou Animal Care Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 104. Shine-moon Suzhou Animal Care Recent Developments
 Table 105. DERMU Corporation Information
 Table 106. DERMU Description and Major Businesses
 Table 107. DERMU Product Models, Descriptions and Specifications
 Table 108. DERMU Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 109. DERMU Recent Developments
 Table 110. Key Raw Materials Distribution
 Table 111. Raw Materials Key Suppliers
 Table 112. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 113. Milestones in Production Technology Evolution
 Table 114. Distributors List
 Table 115. Market Trends and Market Evolution
 Table 116. Market Drivers and Opportunities
 Table 117. Market Challenges, Risks, and Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources


List of Figures
 Figure 1. Veterinary Needle-free Injection Device Product Picture
 Figure 2. Global Veterinary Needle-free Injection Device Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Battery Powered Product Picture
 Figure 4. Compressed Gas Powered Product Picture
 Figure 5. Global Veterinary Needle-free Injection Device Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Pigs
 Figure 7. Cattle
 Figure 8. Poultry
 Figure 9. Companion Animals
 Figure 10. Others
 Figure 11. Veterinary Needle-free Injection Device Report Years Considered
 Figure 12. Global Veterinary Needle-free Injection Device Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Veterinary Needle-free Injection Device Revenue (2020-2031) & (US$ Million)
 Figure 14. Global Veterinary Needle-free Injection Device Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 15. Global Veterinary Needle-free Injection Device Revenue Market Share by Region (2020-2031)
 Figure 16. Global Veterinary Needle-free Injection Device Sales (2020-2031) & (K Units)
 Figure 17. Global Veterinary Needle-free Injection Device Sales (CAGR) by Region (2020-2031) (K Units)
 Figure 18. Global Veterinary Needle-free Injection Device Sales Market Share by Region (2020-2031)
 Figure 19. Top 5 and Top 10 Manufacturers Veterinary Needle-free Injection Device Sales Volume Market Share in 2024
 Figure 20. Global Veterinary Needle-free Injection Device Revenue Market Share Ranking (2024)
 Figure 21. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 22. Battery Powered Revenue Market Share by Manufacturer in 2024
 Figure 23. Compressed Gas Powered Revenue Market Share by Manufacturer in 2024
 Figure 24. Global Veterinary Needle-free Injection Device Sales Market Share by Type (2020-2031)
 Figure 25. Global Veterinary Needle-free Injection Device Revenue Market Share by Type (2020-2031)
 Figure 26. Global Veterinary Needle-free Injection Device Sales Market Share by Application (2020-2031)
 Figure 27. Global Veterinary Needle-free Injection Device Revenue Market Share by Application (2020-2031)
 Figure 28. North America Veterinary Needle-free Injection Device Sales YoY (2020-2031) & (K Units)
 Figure 29. North America Veterinary Needle-free Injection Device Revenue YoY (2020-2031) & (US$ Million)
 Figure 30. North America Top 5 Manufacturers Veterinary Needle-free Injection Device Sales Revenue (US$ Million) in 2024
 Figure 31. North America Veterinary Needle-free Injection Device Sales Volume (K Units) by Type (2020- 2031)
 Figure 32. North America Veterinary Needle-free Injection Device Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 33. North America Veterinary Needle-free Injection Device Sales Volume (K Units) by Application (2020-2031)
 Figure 34. North America Veterinary Needle-free Injection Device Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 35. US Veterinary Needle-free Injection Device Revenue (2020-2031) & (US$ Million)
 Figure 36. Canada Veterinary Needle-free Injection Device Revenue (2020-2031) & (US$ Million)
 Figure 37. Mexico Veterinary Needle-free Injection Device Revenue (2020-2031) & (US$ Million)
 Figure 38. Europe Veterinary Needle-free Injection Device Sales YoY (2020-2031) & (K Units)
 Figure 39. Europe Veterinary Needle-free Injection Device Revenue YoY (2020-2031) & (US$ Million)
 Figure 40. Europe Top 5 Manufacturers Veterinary Needle-free Injection Device Sales Revenue (US$ Million) in 2024
 Figure 41. Europe Veterinary Needle-free Injection Device Sales Volume (K Units) by Type (2020-2031)
 Figure 42. Europe Veterinary Needle-free Injection Device Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 43. Europe Veterinary Needle-free Injection Device Sales Volume (K Units) by Application (2020-2031)
 Figure 44. Europe Veterinary Needle-free Injection Device Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 45. Germany Veterinary Needle-free Injection Device Revenue (2020-2031) & (US$ Million)
 Figure 46. France Veterinary Needle-free Injection Device Revenue (2020-2031) & (US$ Million)
 Figure 47. U.K. Veterinary Needle-free Injection Device Revenue (2020-2031) & (US$ Million)
 Figure 48. Italy Veterinary Needle-free Injection Device Revenue (2020-2031) & (US$ Million)
 Figure 49. Russia Veterinary Needle-free Injection Device Revenue (2020-2031) & (US$ Million)
 Figure 50. Asia-Pacific Veterinary Needle-free Injection Device Sales YoY (2020-2031) & (K Units)
 Figure 51. Asia-Pacific Veterinary Needle-free Injection Device Revenue YoY (2020-2031) & (US$ Million)
 Figure 52. Asia-Pacific Top 8 Manufacturers Veterinary Needle-free Injection Device Sales Revenue (US$ Million) in 2024
 Figure 53. Asia-Pacific Veterinary Needle-free Injection Device Sales Volume (K Units) by Type (2020- 2031)
 Figure 54. Asia-Pacific Veterinary Needle-free Injection Device Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 55. Asia-Pacific Veterinary Needle-free Injection Device Sales Volume (K Units) by Application (2020-2031)
 Figure 56. Asia-Pacific Veterinary Needle-free Injection Device Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 57. Indonesia Veterinary Needle-free Injection Device Revenue (2020-2031) & (US$ Million)
 Figure 58. Japan Veterinary Needle-free Injection Device Revenue (2020-2031) & (US$ Million)
 Figure 59. South Korea Veterinary Needle-free Injection Device Revenue (2020-2031) & (US$ Million)
 Figure 60. China Taiwan Veterinary Needle-free Injection Device Revenue (2020-2031) & (US$ Million)
 Figure 61. India Veterinary Needle-free Injection Device Revenue (2020-2031) & (US$ Million)
 Figure 62. Central and South America Veterinary Needle-free Injection Device Sales YoY (2020-2031) & (K Units)
 Figure 63. Central and South America Veterinary Needle-free Injection Device Revenue YoY (2020-2031) & (US$ Million)
 Figure 64. Central and South America Top 5 Manufacturers Veterinary Needle-free Injection Device Sales Revenue (US$ Million) in 2024
 Figure 65. Central and South America Veterinary Needle-free Injection Device Sales Volume (K Units) by Type (2021-2031)
 Figure 66. Central and South America Veterinary Needle-free Injection Device Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 67. Central and South America Veterinary Needle-free Injection Device Sales Volume (K Units) by Application (2020-2031)
 Figure 68. Central and South America Veterinary Needle-free Injection Device Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 69. Brazil Veterinary Needle-free Injection Device Revenue (2020-2025) & (US$ Million)
 Figure 70. Argentina Veterinary Needle-free Injection Device Revenue (2020-2025) & (US$ Million)
 Figure 71. Middle East, and Africa Veterinary Needle-free Injection Device Sales YoY (2020-2031) & (K Units)
 Figure 72. Middle East and Africa Veterinary Needle-free Injection Device Revenue YoY (2020-2031) & (US$ Million)
 Figure 73. Middle East and Africa Top 5 Manufacturers Veterinary Needle-free Injection Device Sales Revenue (US$ Million) in 2024
 Figure 74. Middle East and Africa Veterinary Needle-free Injection Device Sales Volume (K Units) by Type (2021-2031)
 Figure 75. South America Veterinary Needle-free Injection Device Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 76. Middle East and Africa Veterinary Needle-free Injection Device Sales Volume (K Units) by Application (2020-2031)
 Figure 77. Middle East and Africa Veterinary Needle-free Injection Device Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 78. GCC Countries Veterinary Needle-free Injection Device Revenue (2020-2025) & (US$ Million)
 Figure 79. Turkey Veterinary Needle-free Injection Device Revenue (2020-2025) & (US$ Million)
 Figure 80. Egypt Veterinary Needle-free Injection Device Revenue (2020-2025) & (US$ Million)
 Figure 81. South Africa Veterinary Needle-free Injection Device Revenue (2020-2025) & (US$ Million)
 Figure 82. Veterinary Needle-free Injection Device Industry Chain Mapping
 Figure 83. Regional Veterinary Needle-free Injection Device Manufacturing Base Distribution (%)
 Figure 84. Global Veterinary Needle-free Injection Device Production Market Share by Region (2020-2031)
 Figure 85. Veterinary Needle-free Injection Device Production Process
 Figure 86. Regional Veterinary Needle-free Injection Device Production Cost Structure
 Figure 87. Channels of Distribution (Direct Vs Distribution)
 Figure 88. Bottom-up and Top-down Approaches for This Report
 Figure 89. Data Triangulation
 Figure 90. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona